Dividend17 Aug 2026, 03:46 pm
Medicamen Biotech Fixes Record Date for Final Dividend
AI Summary
Medicamen Biotech Limited has announced that the Board of Directors has fixed September 19, 2026, as the record date for the declaration of a final dividend for the Financial Year 2025-26. The dividend, proposed at 10% or Re. 1/- per equity share, is subject to shareholder approval at the upcoming 33rd Annual General Meeting. The AGM is scheduled for September 26, 2026, to be held via Video Conferencing. The company also approved the draft Annual Report and Cost Audit Report for FY 2025-26 and noted recent communications from stock exchanges regarding compliance matters.
Key Highlights
- Record date for final dividend set as September 19, 2026.
- Proposed final dividend is 10% (Re. 1/- per share).
- 33rd AGM scheduled for September 26, 2026, via VC/OAVM.
- Draft Annual Report and Cost Audit Report approved.
- Board noted stock exchange compliance communications.
Price Impact
More from MEDICAMEQ